...
【24h】

Pathologic evaluation of surgical margins and local recurrences after breast-conserving surgery without irradiation.

机译:无辐射保乳手术后手术切缘和局部复发的病理学评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study was undertaken to evaluate the status of margins of the excised breast tissue using our own method. We also determined the indications for breast-conserving surgery without irradiation by examining the characteristics of patients with local recurrence and comparing relapse-free survival (RFS) and overall survival (OS) of patients who underwent wide excision without irradiation with those of 267 patients who underwent total mastectomy. Eighty-two patients with a 3 cm diameter or less invasive carcinoma were treated with wide excision and axillary dissection between 1987 and 1996. Patients who histologically had four or more axillary lymph node metastases, positive pathologic margins, or a high degree of in situ ductal carcinoma around the main tumor in consecutive step-sections were excluded from this study. During a median follow-up of 6 years (range 2-11 years), six patients (7.3%) had local recurrence and five (6.0%) had regional or distant recurrences as their site of first failure. At 11 years the life-table values for RFS and OS for the wide excision-treated group were 84.7% and 92.1%, respectively, compared with 85.0% and 90.0%, respectively, for patients treated by total mastectomy. RFS and OS were similar in the two treatment groups. Results in the present study indicate that if the patients treated by breast-conserving surgery are carefully selected and there are no foci in the pathologic margins, there is a low degree of in situ ductal carcinoma around the tumor, and no multicentricity, it might be unnecessary to administer
机译:使用我们自己的方法进行了这项研究,以评估切除的乳房组织边缘的状态。我们还通过检查局部复发患者的特征,并比较了接受无辐射广泛切除的患者的无复发生存期(RFS)和总体生存期(OS)与267例接受放射治疗的乳腺癌患者的无复发生存期(RFS)和总体生存期(OS),确定了保留乳房手术的适应症。进行全乳切除。在1987年至1996年之间,对82例直径3 cm或更小的浸润性癌患者进行了广泛切除和腋窝淋巴结清扫术。组织学上有四个或更多腋窝淋巴结转移,阳性病理切缘或高度原位导管的患者本研究排除了连续步骤中主要肿瘤周围的癌。在为期6年(范围2-11年)的中位随访期间,有6例(7.3%)患者局部复发,其中5例(6.0%)局部或远处复发为首次复发部位。在11年时,广泛切除治疗组的RFS和OS寿命表值分别为84.7%和92.1%,而全乳切除术的患者分别为85.0%和90.0%。在两个治疗组中,RFS和OS相似。本研究的结果表明,如果精心选择保留乳房的手术患者,并且在病理边缘没有病灶,肿瘤周围的原位导管癌程度低,并且没有多中心性,则可能是不必要管理

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号